These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32650210)

  • 1. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
    Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
    Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome.
    Kozak KR; Mahadevan A; Moody JS
    Neuro Oncol; 2009 Apr; 11(2):183-91. PubMed ID: 18780813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
    Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
    J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database.
    Shieh LT; Ho CH; Guo HR; Huang CC; Ho YC; Ho SY
    Front Neurol; 2021; 12():659921. PubMed ID: 34899553
    [No Abstract]   [Full Text] [Related]  

  • 7. Gliosarcoma: a clinical and radiological analysis of 48 cases.
    Yi X; Cao H; Tang H; Gong G; Hu Z; Liao W; Sun L; Chen BT; Li X
    Eur Radiol; 2019 Jan; 29(1):429-438. PubMed ID: 29948068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.
    Cheng CD; Chen C; Wang L; Dong YF; Yang Y; Chen YN; Niu WX; Wang WC; Liu QS; Niu CS
    Anal Cell Pathol (Amst); 2022; 2022():2376288. PubMed ID: 35757013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
    Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
    J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.
    Pietschmann S; von Bueren AO; Kerber MJ; Baumert BG; Kortmann RD; Müller K
    PLoS One; 2015; 10(4):e0121592. PubMed ID: 25860797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database.
    Wright JM; Hodges TR; Wright CH; Gittleman H; Zhou X; Duncan K; Kruchko C; Sloan A; Barnholtz-Sloan JS
    J Neurooncol; 2019 Jun; 143(2):349-357. PubMed ID: 30989622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
    Kiang KM; Chan AA; Leung GK
    BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis and management of gliosarcoma patients: A review of literature.
    Saadeh F; El Iskandarani S; Najjar M; Assi HI
    Clin Neurol Neurosurg; 2019 Jul; 182():98-103. PubMed ID: 31112812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.
    Shabihkhani M; Telesca D; Movassaghi M; Naeini YB; Naeini KM; Hojat SA; Gupta D; Lucey GM; Ontiveros M; Wang MW; Hanna LS; Sanchez DE; Mareninov S; Khanlou N; Vinters HV; Bergsneider M; Nghiemphu PL; Lai A; Liau LM; Cloughesy TF; Yong WH
    J Neurooncol; 2017 Apr; 132(2):351-358. PubMed ID: 28161760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
    Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
    J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic and molecular prognostic review of glioblastoma.
    Thakkar JP; Dolecek TA; Horbinski C; Ostrom QT; Lightner DD; Barnholtz-Sloan JS; Villano JL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1985-96. PubMed ID: 25053711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments of gliosarcoma of the brain: a systematic review and meta-analysis.
    Wang X; Jiang J; Liu M; You C
    Acta Neurol Belg; 2021 Dec; 121(6):1789-1797. PubMed ID: 33156945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
    J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
    Kozak KR; Moody JS
    Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and clinical outcomes in adult primary gliosarcoma patients: a Surveillance, Epidemiology, and End Results (SEER) analysis from 2004 to 2015.
    Huang Q; Li F; Chen Y; Hong F; Wang H; Chen J
    Br J Neurosurg; 2020 Apr; 34(2):161-167. PubMed ID: 31829033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.